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A large body of publications mentioning
prominin-1 (Prom1, CD133) is related to
its use as a stem and cancer stem cell marker
(1). Besides progenitor cells, its expression
is widespread throughout terminally differ-
entiated cells as those found in glandular
organs (e.g., pancreas) and retina (2). Yet,
the amino acid sequence of Prom1 didn’t
reveal any motif or potential enzymatic
activity that could explain its molecular
function (3). Nonetheless, its implication
in cellular physiology has been addressed
in several cellular systems and animal mod-
els. In particular, the effect of Prom1 gene
ablation has been investigated in different
tissues and organs (Table 1, top). In the
above-mentioned article (4), erroneously
qualified by its authors as “the first study to
provide an in-depth evaluation of the role
and function of Prom1”, several features of
a new Prom1-/- mouse were highlighted
that were not described in previous Prom1-
deficient murine models, raising questions
about the influence of the genetic back-
grounds on the penetrance and variable
expressivity. To understand these issues,
it is important to have an accurate view
on the implication of Prom1 in molecu-
lar processes leading to tissue homeostasis
and diseases. Unfortunately, valuable infor-
mation that could potentially enlighten
some of the data reported was omitted (4).
Moreover, the genetic construct and the
characterization of their model (protein
expression) were missing, thus preventing
direct comparison with previous works. We
propose to provide the readers of Fron-
tiers in Oncology with a larger context for
the observations of Karim et al. and the
potential functions of Prom1.
In humans, several mutations in
PROM1 gene affecting the open reading
frame were found to be associated with
retinitis pigmentosa, macular degenera-
tion, and cone-rod dystrophy (Table 1,
bottom). Despite the extended expres-
sion of PROM1, little phenotypical effects
were observed beyond the visual sys-
tem. Extensive clinical analysis of patients
carrying PROM1 R373C mutation sug-
gested that endothelial function could be
affected despite apparently normal levels
of endothelial progenitor cells (23). Neuro-
imaging revealed many small lesions in
the cerebral white matter in three patients.
The expression of Prom1 in myelinating
oligodendrocytes might be relevant in this
context (24). Some carriers of the R373C
mutation showed memory disturbance and
impairment in measured executive func-
tions, suggesting that the lack of functional
PROM1 may not solely affect photorecep-
tor cells. Yet, the penetrance was variable,
calling for larger studies to confirm these
findings (23).
In the first description of Prom-1-/-
mice, they were reported as viable and fer-
tile, with a normal lifespan and no obvious
abnormalities upon macroscopic inspec-
tion and histological analysis of various
organs other than a progressive photore-
ceptor degeneration leading to complete
loss of vision (5), thus constituting a mouse
model of the human diseases. These obser-
vations have been recently confirmed in
an independent Prom1-deficient murine
model that also revealed that this degen-
eration was light dependent, consistent
with what is observed in Stargardt’s disease
patients (10). Interestingly, variations in
the genetic background influenced the pro-
gression of photoreceptor cell degenera-
tion (10). In addition to engineered animal
models, a spontaneous knockout mouse
(Prom1rd19) carrying single point mutation
in Prom1 gene was reported with retinal
degeneration and abnormal retinal blood
vessel morphology (Table 1). Moreover,
using a transgenic knock-in mouse carry-
ing the human dominant R373C mutation,
Yang et al. could demonstrate the struc-
tural involvement of Prom1 in photorecep-
tor morphogenesis (17). As a cholesterol-
binding protein associated with membrane
microdomains, Prom1 could provide a
proper membrane lipid composition and
synchronize various steps in the outer seg-
ment biogenesis. Whether the new mouse
line of Karim et al. also suffers visual
impairment is not known but it appears to
present several features not yet described
(4).
Notably, they noted compromised sper-
matogenesis in “some Prom1-/- males” (4).
It would be interesting to know what
proportion is affected, since Prom1 is
expressed in the male reproductive tract
of mouse and human (25, 26), and is
detected in mouse spermatozoa found in
the testes and the epididymis (25, 27, 28).
Similarly, the mature obesity in Prom1-/-
mice reported by Karim et al. based on
≈15% increase in body weight over a 13-
week period compared to wild type is dif-
ferent from earlier studies (Table 1), and
may reflect the influence of genetic back-
ground on the permeability to metabolic
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Table 1 | Prom1 genetically modified murine models and mutations in human PROM1 gene.
Genotype Disrupting
exon Gene
ID 19126
Type Background Reported phenotype Reference
Murine models with genetically modified prom1 gene
Prom1-/- Exon 2 Constitutive knockout Congenic
C57BL/6
Disk dysmorphogenesis and
photoreceptor degeneration
(5)
50/50
129/swiss
Reduced branching in mammary gland (6)
Enhanced ratio of luminal to basal cell
Congenic
C57BL/6
JOlaHsd
Normal blood cells pool size (7)
Reduced frequencies of growth
factor-responsive myeloerythroid
precursor cells in vitro
C57BL/6 Normal proliferation of precursor cells
in adult hippocampus subgranular zone
(8)
Reduced number of new neurons
surviving
Prom1lacZ,DTA/lacZ,DTA Exon 2 LacZ knockin C57BL/6 No abnormal phenotype (9)
C57BL/6 Photoreceptor cell degeneration (10)
Difficulty in breeding
C57BL/6
xCBA/NSlc
Photoreceptor cell degeneration with
slower progression
Prom1lacZ,DTA/+;
CreERTM
Exon 2 Conditional ablation of
Prom1-expressing cells upon DTA
expression by tamoxifen-induced
Cre mediated recombination
C57BL/6
xCBAxSJL
Abnormal nervous system morphology (9)
Reduced body weight
Walking abnormality (cerebellum
functional defect)
Prom1C-L/C-L Exon 2
(first ATG)
CreER LacZ knockin C57BL/6 No abnormal phenotype (11)
Prom1C-L/Prom1+;
Rosa26-YFP;
Ctnnb1+/lox(ex3)
Exon 2
(first ATG)
Conditional activation of
endogenous Wnt signaling in
Prom1-expressing cells by
tamoxifen-induced Cre mediated
recombination and lineage tracing
– Increased intestinal adenocarcinoma
incidence after tamoxifen
administration
(11)
Prom1rd19 Exon 9 Spontaneous knockout (premature
STOP codon; K269X)
BXD83/RwwJ Retinal degeneration
Abnormal retinal blood vessel
morphology
http://www.
informatics.
jax.org/allele/
MGI:5605699
Prom1lacZ/+ Exon 3–8 Expression reporter C57BL/6J No phenotype analysis, expression
assay
(12)
Prom1-mCherry-IRES-CreERT2;
Rosa26-LacZ
Disruption
of the STOP
codon
Fusion protein
Lineage tracing
– No phenotype analysis (13)
Prom1-/- ? 129SvEv Mature obesity (4)
Moderate degree of germinal arrest
Increase in fasting blood glucose
(Continued)
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Table 1 | Continued
Mutation Molecular defect Pathology Reference
Mutations in human prom1 gene that affect its open reading frame
c.1878delG Frame-shift from codon 614a onward causing premature STOP Autosomal recessive retinitis
pigmentosa
(14)
codon after the addition of 12 amino acids; G614fs12X
Polydactyly
c.1726C >T Premature STOP codon; Q576X Severe forms of rod-cone degeneration
consistent with retinitis pigmentosa
(15)
c.1349_1350insT Frame-shift from codon 452 onward causing a premature STOP Autosomal recessive cone-rod
dystrophy
(16)
codon after the addition of 12 amino acids (exon12) Y452fs12X
c.1117C >T Single amino acid substitution; R373C Autosomal dominant macular
dystrophy
(17, 18)
Possible impairment in endothelial
progenitor cell functionality
c.869delG Frame-shift from codon 289 onward causing a premature STOP Retinitis pigmentosa and macula
degeneration
(19)
codon after the addition of one amino acid; S289fs1X
c.442A >T Premature STOP codon; K148X Retinitis pigmentosa (20)
aAccording to the sequence of P rominin-1.s2 splice variant [for nomenclature of splice variants see Ref. (21)]. Mutations are indicated according to the proposed
nomenclature (22).
?, not described.
disorders. In fact, in a conditional abla-
tion model, tamoxifen-induced ablation
of Prom1-expressing cells caused body
weight loss (9). Studies have pointed to
the potential involvement of Prom1 in
cellular metabolism in rat myotubes and
mouse pancreatic islets with contrasting
findings (29, 30), and an increase in Prom1
expression in young mice with induced
obesity has been reported (31). In other
respects, PROM1 was shown to promote
glucose uptake in a human hepatocellu-
lar carcinoma cell line (32). Karim et al.
also indicated an increase in blood glu-
cose levels and therefore suggested a link
between Prom1 and pancreatic function
(4). Although the metabolic features of
Prom1-/- mice need to be more thoroughly
investigated (e.g., insulinemia, gain in adi-
pose tissue, glucose tolerance), it is worth
mentioning that Prom1 labels fetal mouse
and human islet progenitor cells (33, 34)
and was used for isolation of pancreatic
ductal progenitor cells (35). PROM1 is
expressed in ductal cells of the exocrine
component of adult pancreas (36–38).
The novel Prom1-/- mouse was main-
tained in 129SvEv, a less phenotypi-
cally characterized background than the
frequent C57BL/6 and might be more
permissive to the expression of these char-
acters. Therefore, whether the differences
in various Prom1-deficient mice are related
to strain, the different background (39),
environmental factors, or the construct
would require further studies. Yet, the var-
ious cellular activities with which Prom1
has been associated are in line with our
early suggestion that Prom1 can act as reg-
ulator in the organization and functionality
of plasmalemma protrusions (40). Hence,
its absence may cause alterations in cel-
lular adhesion and/or signaling pathways.
Although the phenotypic consequences of
Prom1 defect seem to be limited, despite
a broad tissue expression, to a restricted
number of organs especially those devoid
of prominin-2 (e.g., retina and testes) (3,
27), a careful examination over longer peri-
ods of time may uncover the expression of
subtle changes in functionality in specific
tissues.
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